Product
Cablivi®
1 clinical trial
1 indication
Indication
Thrombotic thrombocytopenic purpuraClinical trial
Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP)- REACT-2020Status: Recruiting, Estimated PCD: 2024-10-01